entertainment -WSS

entertainment

author：focus 2025-09-27 16:47:53 - browse：3

FDA stop sign — Sarah Silbiger/Getty Images

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products.

The regulator this week posted warning letters that it sent to two websites, Synthetix Inc. DBA Helix Chemical Supply and US Chem Labs. Though those websites say their chemicals are “for research use” and “not for human consumption,” the FDA said it found evidence on their pages showing that their products are indeed intended for human use, such as information about dosing and claims about the clinical benefits of the products.

The two websites did not immediately respond to requests for comment. The FDA said they have 15 working days to respond and detail the steps they’ve taken to address any violations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Medicare reduced heart disease by changing how it pays doctors

WSS

Behind warning on Apellis’s eye drug lies a conflict of interest

Interest rates are at a 22

HHS leader on health, climate change and biopharma emissions

Will biotech layoffs continue through 2023?

STAT Summit: How a Chicago ER doctor tackles gun violence

The EU Joint Clinical Assessment needs to live up to its promise

focus

entertainment

focus

Dobbs anniversary: the lost opportunity of abortion as health care

Public health communication lessons from Covid

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

FDA struggles to regulate food additives, sometimes for decades

Continuity nursing helped my family in our darkest PICU moments

Ending health disparities requires full federal government, panel says

Walensky prepares to leave CDC — and Congress — behind

VC firm RA Capital starts a new synthetic biology incubator

Hollywood unions extend contract negotiations for actors

Impact of Dobbs ruling felt at reproductive medicine meeting

hotspot

The mammogram wars are not over

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

Interest rates are at a 22

How climate

Stoke drug shows lower activity against childhood epilepsy

Public health communication lessons from Covid

Wikipedia

focus

hotspot

hotspot